Levomenol

2D Structure
CID	442343
Target	/
IUPAC Name	(2S)-6-methyl-2-[(1S)-4-methylcyclohex-3-en-1-yl]hept-5-en-2-ol
InChI	InChI=1S/C15H26O/c1-12(2)6-5-11-15(4,16)14-9-7-13(3)8-10-14/h6-7,14,16H,5,8-11H2,1-4H3/t14-,15+/m1/s1
InChI Key	RGZSQWQPBWRIAQ-CABCVRRESA-N
Canonical SMILES	CC1=CCC(CC1)C(C)(CCC=C(C)C)O
Isomeric SMILES	CC1=CC[C@H](CC1)[C@](C)(CCC=C(C)C)O
Molecular Formula	C15H26O
Molecular Weight	222.37
synonyms	['LEVOMENOL', '23089-26-1', '(-)-alpha-Bisabolol', 'alpha-(-)-Bisabolol', 'Levomenolum', 'Kamilosan', '1-alpha-Bisabolol', 'alpha-Bisabolol, L-', 'alpha-Bisabolol (-)-form', 'UNII-24WE03BX2T', '24WE03BX2T', 'CCRIS 9081', '(-)-6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol', 'DTXSID4042094', 'EINECS 245-423-3', 'Levomenolum [INN-Latin]', 'DTXCID2022094', '3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (alphaS,1S)-', 'Levomenolum (INN-Latin)', 'LEVOMENOL (MART.)', 'LEVOMENOL [MART.]', 'LEVOMENOL (USP-RS)', 'LEVOMENOL [USP-RS]', '3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (S-(theta,theta))-', 'PurpleU BAOBAB FACE', 'BISABOLOL, (-)-alpha', 'alpha-BISABOLOL, (-)-', '(alphaS,1S)-alpha-BISABOLOL', '(-)-alpha-BISABOLOL (CONSTITUENT OF CHAMOMILE)', '5-HEPTEN-2-OL, 6-METHYL-2-(4-METHYL-3-CYCLOHEXEN-1-YL), (-)-', '245-423-3', '3-CYCLOHEXENE-1-METHANOL, alpha,4-DIMETHYL-alpha-(4-METHYL-3-PENTEN-1-YL)-, (alphaS,1S)-', 'Kamillosan', 'alpha-Bisabolol', 'Bisabolol', '.alpha.-Bisabolol', 'Levomenol [INN]', '(2S)-6-methyl-2-[(1S)-4-methylcyclohex-3-en-1-yl]hept-5-en-2-ol', '3-Cyclohexene-1-methanol, a,4-dimethyl-a-(4-methyl-3-pentenyl)-,(aS,1S)-', '(-)-.alpha.-Bisabolol', 'Bisabolol, (-)-.alpha.', '.alpha.-bisabolol, (-)-', 'CHEBI:125', '.alpha.-Bisabolol (-)-form', 'FEMA NO. 4666', '(S)-6-Methyl-2-((S)-4-methylcyclohex-3-en-1-yl)hept-5-en-2-ol', '(.alpha.s,1s)-.alpha.-bisabolol', 'Dragosantol (>80%)', 'Dragosantol', 'Camilol', 'Levomenol; (-)-a-Bisabolol', 'Hydagen B', '(-)-\|A-Bisabolol', '((-))-6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol', '515-69-5', 'BISABOLOL, ALPHA', 'BISABOLOL, .ALPHA.', 'RACEMIC ALFA-BISABOLOL', 'Bisbalol', 'BISABOLA-1,12-DIEN-8-OL', 'L-alpha-Bisabolol', 'Levomenol, INN', '3-Cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-pentenyl)-, [S-(R,R)]-', '(-)-a-Bisabolol', 'MFCD03412455', 'l-.alpha.-Bisabolol', 'Levomenol (Standard)', '(-)-?-Bisabolol', '(?)-\|A-Bisabolol', '.alpha.-Bisabolol, L-', '(-)- alpha -Bisabolol', '.alpha.-(-)-Bisabolol', 'BISABOLOL [VANDF]', '(-)--BISABOLOL', 'ALPHA-(-)BISABOLOL', 'LEVOMENOL [WHO-DD]', 'SCHEMBL24989', 'CHEMBL1096927', 'HY-N6967R', '(-)-(4S,8S)-alpha-Bisabolol', '(-)-alpha-Bisabolol (Levomenol)', 'GLXC-20390', 'HY-N6967', '[S-(R,R)]-.alpha.-Bisabolol', 'Tox21_301375', '5-Hepten-2-ol, 6-methyl-2-(4-methyl-3-cyclohexen-1-yl)-, (-)-', 'BDBM50382730', 'NSC782530', 'Levomenol 100 microg/mL in Methanol', 'DB13153', 'FB75117', 'LMPR0103060001', 'NSC-782530', '(-)-alpha-Bisabolol, >=93% (GC)', '(-)-Alpha-bisabolol(-)-alpha-bisabolol', 'NCGC00255987-01', '(-)-alpha-Bisabolol, analytical standard', 'DA-74979', 'TS-09816', '.ALPHA.-BISABOLOL (-)-FORM [MI]', 'CAS-23089-26-1', 'CS-0028206', 'NS00068750', 'C09621', 'G13201', 'EN300-19632355', 'Q179896', 'BRD-K62751771-001-01-3', '(-)-alpha-Bisabolol, primary pharmaceutical reference standard', 'Levomenol, United States Pharmacopeia (USP) Reference Standard', '(-)-.ALPHA.-BISABOLOL (CONSTITUENT OF CHAMOMILE) [DSC]', '6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol, (-)-', '5-HEPTEN-2-OL, 6-METHYL-2-(4- METHYL-3-CYCLOHEXEN-1-YL), (-)-', '[S-(R,R)]-.alpha.,4-Dimethyl-.alpha.-(4-methyl-3-pentenyl)cyclohex-3-ene-1-methanol', '3-Cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-pentenyl)-, (-)-', '3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (.alpha.S,1S)-', 'alpha,4-Dimethyl-alpha-(4-methyl-3-penten-1-yl)-(alphaS,1S)-3-Cyclohexene-1-methanol', '3-CYCLOHEXENE-1-METHANOL, .ALPHA.,4-DIMETHYL-.ALPHA.-(4-METHYL-3-PENTEN-1-YL)-, (.ALPHA.S,1S)-']

From Pubchem